Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.21
  • Today's Change-0.002 / -0.03%
  • Shares traded1.28k
  • 1 Year change+60.31%
  • Beta1.2048
Data delayed at least 15 minutes, as of Nov 13 2024 19:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments78141259
Total Receivables, Net33167.24
Total Inventory0.000.000.00
Prepaid expenses2.622.002.10
Other current assets, total------
Total current assets113158268
Property, plant & equipment, net7.878.219.02
Goodwill, net------
Intangibles, net49440.17
Long term investments4.134.914.43
Note receivable - long term--00.00
Other long term assets0.00----
Total assets174216282
LIABILITIES
Accounts payable108.6112
Accrued expenses4.204.854.10
Notes payable/short-term debt0.0900
Current portion long-term debt/capital leases7.835.072.17
Other current liabilities, total162144
Total current liabilities383963
Total long term debt627072
Total debt707574
Deferred income tax0.460.510.60
Minority interest----0
Other liabilities, total4.731127
Total liabilities106121163
SHAREHOLDERS EQUITY
Common stock121212
Additional paid-in capital445445444
Retained earnings (accumulated deficit)(390)(360)(337)
Treasury stock - common(0.97)(0.98)(0.99)
Unrealized gain (loss)------
Other equity, total1.00(1.35)0.02
Total equity6895119
Total liabilities & shareholders' equity174216282
Total common shares outstanding505050
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.